Skip to main content

Ensysce Biosciences, Inc.

corporate_fare Company Profile

Ensysce Biosciences, Inc.

ENSC·NASDAQ·Life Sciences·CIK 0001716947

Ensysce Biosciences, Inc. is a clinical stage pharmaceutical company focused on developing innovative solutions for severe pain relief. The company aims to reduce the potential for opioid misuse, abuse, and overdose. Ensysce Biosciences is currently developing product candidates designed to improve the safety of prescription drugs. Its primary focus is on opioid pain products and opioid use disorder products. The company was originally incorporated in Delaware in April 2003 as PharmacoFore, Inc., changing its name to Signature Therapeutics Inc. in January 2012. In December 2015, Signature merged with Ensysce Biosciences, Inc. ("Former Ensysce"). In June 2021, Former Ensysce merged with Leisure Acquisition Corporation, which then changed its name to Ensysce Biosciences, Inc. The principal executive office is located at 7946 Ivanhoe Avenue, Suite 201, La Jolla, California 92037.

Ensysce Biosciences, Inc. (NASDAQ:ENSC) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 34 items for ENSC at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-18, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for ENSC spans DEFA14A, 10-Q, DEF 14A, 8-K.

Recent high-impact activity:

  • Ensysce Proxy Supplement: Brokers Gain Discretionary Votes on Reverse Split; Staged Meeting Possible
  • Ensysce Q3 Loss of $4.52/Share Blows Past 12-Cent Consensus as Revenue Jumps 342%
  • Ensysce 10-Q: $29.7M Cash, $82.3M Q3 Loss, Going-Concern Warning and MHRA Setback on CY200
  • Ensysce Sets Dec 14 Vote on 358.3M-Share Series C Conversion, Reverse Split and Share Increase
  • Ensysce Ends Q3 With $29.7M Cash, But MHRA Wants More Data on Lead CRPS Program

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$5.07M
Net Income
-$10.18M
Diluted EPS
-$3.98
Op. Cash Flow
-$7.81M
Free Cash Flow
-$7.93M
Operating Income
-$10.24M
Cash & Equivalents
$4.31M
Debt / Equity
0.00×
Net Margin
-200.8%
Shares Outstanding
4.57M sh
Source: 10-K · filed 2026-03-30 · accession 0001493152-26-013633

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 88,607 shares in ENSC as of the October 30, 2026 settlement, a 70.8% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 13.2% of ENSC volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)88,607 shares as of October 30, 2026
Change vs prior period▼ 70.8%
Days to cover1.00 at avg daily volume of 264,785
Daily short volume (FINRA facilities)13.2% of 50,974 shares on November 20, 2026
5-day average short volume12.1%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for ENSC, detected from its recent SEC filings.

2 shelf registrations

Resale S-3 Covers 433.9M Shares · Overhang Is Roughly 22x Outstanding

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with E →
$0.41 +13.89% today
52-week range · as of 2026-11-18 $0.23 – $2.04
Market cap
$7M
Volume
83.4K (0.2× avg)
3-mo avg 349.7K
Live data · 2026-11-21 14:17 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ENSC - Latest Insights

ENSC
Nov 18, 2026, 5:20 PM EST
Filing Type: DEFA14A
Importance Score:
7
Price at Filing: $0.366
Real-time Price: $0.410 info
Change: +$0.044 (+12%) info
Market Cap: $7.004M info
ENSC
Nov 12, 2026, 11:18 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $0.380
Real-time Price: $0.410 info
Change: +$0.030 (+8%) info
Market Cap: $7.004M info
ENSC
Nov 12, 2026, 4:30 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.3871
Real-time Price: $0.410 info
Change: +$0.0229 (+6%) info
Market Cap: $7.004M info
ENSC
Nov 12, 2026, 4:17 PM EST
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $0.3871
Real-time Price: $0.410 info
Change: +$0.0229 (+6%) info
Market Cap: $7.004M info
ENSC
Nov 12, 2026, 4:15 PM EST
Source: ACCESS Newswire
Importance Score:
7
Price at Filing: $0.3871
Real-time Price: $0.410 info
Change: +$0.0229 (+6%) info
Market Cap: $7.004M info
ENSC
Nov 04, 2026, 12:46 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.3719
Real-time Price: $0.410 info
Change: +$0.0381 (+10%) info
Market Cap: $7.004M info
ENSC
Oct 30, 2026, 5:28 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $0.4313
Real-time Price: $0.410 info
Change: -$0.0213 (-5%) info
Market Cap: $7.004M info
ENSC
Oct 23, 2026, 4:30 PM EDT
Filing Type: S-3
Importance Score:
8
Price at Filing: $0.4847
Real-time Price: $0.410 info
Change: -$0.0747 (-15%) info
Market Cap: $7.004M info
ENSC
Oct 15, 2026, 9:56 PM EDT
Filing Type: 8-K/A
Importance Score:
8
Price at Filing: $0.565
Real-time Price: $0.410 info
Change: -$0.155 (-27%) info
Market Cap: $7.004M info
ENSC
Aug 25, 2026, 5:12 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.3905
Real-time Price: $0.410 info
Change: +$0.0195 (+5%) info
Market Cap: $7.004M info
ENSC
Aug 24, 2026, 5:13 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.3593
Real-time Price: $0.410 info
Change: +$0.0507 (+14%) info
Market Cap: $7.004M info
ENSC
Aug 18, 2026, 12:30 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $0.370
Real-time Price: $0.410 info
Change: +$0.040 (+11%) info
Market Cap: $7.004M info
ENSC
Aug 18, 2026, 6:06 AM EDT
Filing Type: 4
Importance Score:
9
Price at Filing: $0.4154
Real-time Price: $0.410 info
Change: -$0.0054 (-1%) info
Market Cap: $7.004M info
ENSC
Aug 13, 2026, 4:25 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $0.3426
Real-time Price: $0.410 info
Change: +$0.0674 (+20%) info
Market Cap: $7.004M info
ENSC
Aug 13, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.343
Real-time Price: $0.410 info
Change: +$0.067 (+20%) info
Market Cap: $7.004M info
ENSC
Aug 06, 2026, 3:45 PM EDT
Filing Type: 8-K/A
Importance Score:
9
Price at Filing: $0.518
Real-time Price: $0.410 info
Change: -$0.108 (-21%) info
Market Cap: $7.004M info
ENSC
Aug 06, 2026, 8:20 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.72375
Real-time Price: $0.410 info
Change: -$0.31375 (-43%) info
Market Cap: $7.004M info
ENSC
Jul 15, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.2914
Real-time Price: $0.410 info
Change: +$0.1186 (+41%) info
Market Cap: $7.004M info
ENSC
Jun 04, 2026, 4:42 PM EDT
Filing Type: S-3
Importance Score:
8
Price at Filing: $0.2999
Real-time Price: $0.410 info
Change: +$0.1101 (+37%) info
Market Cap: $7.004M info
ENSC
May 22, 2026, 4:55 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.3013
Real-time Price: $0.410 info
Change: +$0.1087 (+36%) info
Market Cap: $7.004M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets